Insulin degludec/insulin aspart (IDegAsp) treatment on glycemic control and weight in patients with insulin experienced uncontrolled type 2 diabetes mellitus: A retrospective observational study
, , , , , , und
21. Apr. 2025
Über diesen Artikel
Online veröffentlicht: 21. Apr. 2025
Seitenbereich: 42 - 47
DOI: https://doi.org/10.2478/enr-2025-0006
Schlüsselwörter
© 2025 Ramazan Cakmak et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Cakmak, Ramazan
Division of Endocrinology and Metabolism Disease, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul UniversityIstanbul, Turkey
Division of Endocrinology and Metabolism Disease, Department of Internal Medicine, Gaziosmanpasa Medical Park Hospital, Istinye UniversityIstanbul, Turkey
Caklili, Ozge Telci
Division of Endocrinology and Metabolism Disease, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul UniversityIstanbul, Turkey
Division of Endocrinology and Metabolism Disease, Department of Internal Medicine, Kocaeli City HospitalKocaeli, Turkey
Kapar, Caner
Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul UniversityIstanbul, Turkey
Catma, Yunus
Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul UniversityIstanbul, Turkey
Bayramlar, Osman Faruk
Department of Public Health, Istanbul Health Directorate, Bakirkoy District Health DirectorateIstanbul, Turkey
Calikoglu, Fulya
Division of Endocrinology and Metabolism Disease, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul UniversityIstanbul, Turkey
Karsidag, Kubilay
Division of Endocrinology and Metabolism Disease, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul UniversityIstanbul, Turkey
Dinccag, Nevin
Division of Endocrinology and Metabolism Disease, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul UniversityIstanbul, Turkey